Sotera Health Company Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Sotera Health Company stock have an average target of 20.67, with a low estimate of 16 and a high estimate of 24. The average target predicts an increase of 37.25% from the current stock price of 15.06.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$20.67	$23	$24
Change	+6.24%	+37.25%	+52.72%	+59.36%

Analyst Ratings

The average analyst rating for Sotera Health Company stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	2	2	1	1	1	2
Buy	2	2	2	3	4	4
Hold	1	1	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $21 → $23	Strong Buy	Maintains	$21 → $23	+52.72%	Feb 24, 2026
Sean Dodge RBC Capital	RBC Capital	Buy Initiates $24	Buy	Initiates	$24	+59.36%	Jan 9, 2026
Jason Bednar Piper Sandler	Piper Sandler	Hold → Buy Upgrades $17 → $24	Hold → Buy	Upgrades	$17 → $24	+59.36%	Jan 9, 2026
Max Smock William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 18, 2025
Sean Dodge BMO Capital	BMO Capital	Buy Initiates $19	Buy	Initiates	$19	+26.16%	Nov 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.25B

from 1.16B

7.51%

from 1.16B

Revenue Next Year

1.33B

from 1.25B

6.00%

from 1.25B

EPS This Year

0.97

from 0.27

260.46%

from 0.27

EPS Next Year

1.06

from 0.97

8.64%

from 0.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	931.48M	1.00B	1.05B	1.10B	1.16B	1.25B	1.33B
Revenue Growth	13.85%	7.75%	4.54%	4.88%	5.74%	7.51%	6.00%
EPS	0.41	-0.83	0.18	0.16	0.27	0.97	1.06
EPS Growth	-	-	-	-12.89%	72.20%	260.46%	8.64%
Forward PE	-	-	-	-	-	15.47	14.24
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.3B	1.4B
Avg	1.3B	1.3B
Low	1.2B	1.3B

Revenue Growth

Revenue Growth	2026	2027
High	12.2%	11.1%
Avg	7.5%	6.0%
Low	3.6%	1.9%

EPS Forecast

EPS	2026	2027
High	1.03	1.13
Avg	0.97	1.06
Low	0.89	0.95

EPS Growth

EPS Growth	2026	2027
High	281.1%	16.5%
Avg	260.5%	8.6%
Low	230.3%	-2.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.